Meiyu Geng

This inventor holds 37 USPTO granted patents and 21 published patent applications, plus 23 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Chinese Academy of Sciences, Green Valley (Shanghai) Pharmaceuticals Co., Ltd., Shanghai Haihe Pharmaceutical Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meiyu Geng. Retrieved from https://idiyas.com/inventor/meiyu-geng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 21)

% Patents Active = 89.2

CIPO Patents = 23 (Patent Applications = 14)

EPO Patents = 19 (Patent Applications = 50)

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 35(Granted Patents)

Location History:

Qingdao, CN (2014 - 2019)
Guangdong, CN (2020)
Shanghai, CN (2015 - 2023)

Company Filing History:

31 out of 3,358

Chinese Academy of Sciences

patents

8 out of 8

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

patents

6 out of 9

Shanghai Haihe Pharmaceutical Co., Ltd.

patents

4. 3 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

5. 2 out of 70

Ocean University of China

patents

6. 1 out of 37

China Pharmaceutical University

patents

7. 1 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

patents

8. 1 out of 1

Haihe Biopharma Co., Ltd.

Shanghai Green Valley Pharmaceutical Co., Ltd.

patents

11. 1 out of 1

Shanghai Institute of Materia Medica, Chinese Acad

patent

12. 1 out of 1

Shanghai Runshi Medical Technology Co., Ltd

patent

13. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

CSF-1R Kinase Inhibitor

Pyrazolone Compound

Mannuronic Diacid

Kinase Inhibitory Activity

Pharmaceutical Composition

Algin Oligosaccharides

Indazole Compounds

Fused Ring Compounds

Substituted Amino Compounds

Quinolone Derivatives

Optical Isomers

Fused Cyclic Compounds

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649721 - CSF1R kinase inhibitor and use thereof (2026-06-09),

2. 12605375 - Use of CSF-1R kinase inhibitor (2026-04-21),

3. 12497394 - Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof (2025-12-16),

4. 12492212 - Substituted pyrazolecarboxamides as sting activators (2025-12-09),

5. 12479850 - Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereof (2025-11-25),

6. 12384795 - Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereof (2025-08-12),

7. 12312324 - Fluorine-containing substituted benzothiophene compound, and pharmaceutical composition and application thereof (2025-05-27),

8. 12269838 - Composition of mannuronic diacid (2025-04-08),

9. 11834432 - Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof (2023-12-05),

10. 11661421 - Indolizine compounds, preparation method and use thereof (2023-05-30),

11. 11655239 - Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof (2023-05-23),

12. 11465984 - Compound having ERK kinase inhibitory activity and use thereof (2022-10-11),

13. 11464794 - Composition of alginic oligosaccharic diacids (2022-10-11),

14. 11406659 - Use of mannuronic diacid composition in treatment of inflammation (2022-08-09),

15. 11406654 - Use of mannuronic diacid composition in treatment of Parkinson's disease (2022-08-09),

Title: The Innovative Journey of Meiyu Geng

Introduction: Meiyu Geng, a pioneering inventor hailing from Shanghai, China, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Meiyu Geng's latest patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we perceive transportation technology.

Career Highlights: With a career spanning over two decades, Meiyu Geng has worked tirelessly to bring her innovative ideas to life. Her dedication and passion for technology have led to the development of numerous cutting-edge solutions in various industries.

Collaborations: Throughout her career, Meiyu Geng has collaborated with leading tech companies and research institutions to further enhance her inventions. Her ability to work in diverse teams has resulted in the successful implementation of her groundbreaking ideas.

Conclusion: Meiyu Geng's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a true trailblazer in the world of inventions. Her work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.